Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03984097
Title A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Alabama Oncology Birmingham Alabama 35211 United States Details
Pacific Cancer Care Monterey California 93940 United States Details
American Oncology Partners of Maryland, PA Bethesda Maryland 20817 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Good Samaritan Hospital Cincinnati Ohio 45220 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Froedtert Hospital & the Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field